Drug Shortage Report for FETZIMA
| Report ID | 199542 |
| Drug Identification Number | 02441004 |
| Brand name | FETZIMA |
| Common or Proper name | Fetzima ER 120 mg capsules |
| Company Name | ABBVIE CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | LEVOMILNACIPRAN |
| Strength(s) | 120MG |
| Dosage form(s) | CAPSULE (EXTENDED RELEASE) |
| Route of administration | ORAL ORAL |
| Packaging size | 30 capsules bottle |
| ATC code | N06AX |
| ATC description | |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2023-07-24 |
| Actual start date | |
| Estimated end date | 2023-08-15 |
| Actual end date | 2023-08-15 |
| Shortage status | Resolved |
| Updated date | 2023-08-16 |
| Company comments | 20, 40 & 80 mg strengths continue to remain available |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 8401 TRANS-CANADA HIGHWAY SAINT-LAURENT, QUEBEC CANADA H4S 1Z1 |
| Company contact information | Should you require any additional information, please contact our Customer Service Department at 1-888-704-8270. |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2023-08-16 | English | Compare |
| v7 | 2023-08-15 | French | Compare |
| v6 | 2023-08-15 | English | Compare |
| v5 | 2023-08-11 | French | Compare |
| v4 | 2023-08-11 | English | Compare |
| v3 | 2023-07-25 | English | Compare |
| v2 | 2023-07-21 | French | Compare |
| v1 | 2023-07-21 | English | Compare |
Showing 1 to 8 of 8